Literature DB >> 11489168

Susceptibility of tumour necrosis factor-alpha genetically deficient mice to Trypanosoma congolense infection.

F Iraqi1, K Sekikawa, J Rowlands, A Teale.   

Abstract

The TNF-alpha gene on mouse chromosome MMU17 is among the candidates for the trypanosomosis resistance QTL Tir1. Tir1 has the largest effect of those loci so far detected which influence degree of resistance to murine trypanosomosis caused by Trypanosoma congolense infection. We therefore studied the survival to 180 days after challenge with T. congolense of mice that were homozygous and hemizygous with respect to a disruption of the TNF-alpha gene on a > 99% C57BL/6 (resistant) background. We also examined the responses of TNF-alpha hemizygous mice produced by crossing the deletion line with mice of the C57BL/6J strain, and with mice of the susceptible A/J strain. Mice lacking a functional TNF-alpha gene were shown to be highly susceptible to challenge with T. congolense with a median survival time of 37 days. This was comparable to 71 days for control wild-type mice, and 61 and 111 days for mice of the susceptible A/J and resistant C57BL/6J strains, respectively. In mice of the deletion line, the C57BL/6 TNF-alpha allele tended to be dominant to the TNF knockout in terms of resistance. We conclude that TNF-alpha plays an important role in resistance to the effects of T. congolense infection in mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489168     DOI: 10.1046/j.1365-3024.2001.00401.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  7 in total

1.  Collaborative Cross mice and their power to map host susceptibility to Aspergillus fumigatus infection.

Authors:  Caroline Durrant; Hanna Tayem; Binnaz Yalcin; James Cleak; Leo Goodstadt; Fernando Pardo-Manuel de Villena; Richard Mott; Fuad A Iraqi
Journal:  Genome Res       Date:  2011-04-14       Impact factor: 9.043

2.  TNF-alpha mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection.

Authors:  J Naessens; H Kitani; Y Nakamura; Y Yagi; K Sekikawa; F Iraqi
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

3.  Recombinant tumor necrosis factor alpha does not inhibit the growth of African trypanosomes in axenic cultures.

Authors:  Hiroshi Kitani; Samuel J Black; Yoshio Nakamura; Jan Naessens; Noel B Murphy; Yuichi Yokomizo; John Gibson; Fuad Iraqi
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Susceptibility of heat shock protein 70.1-deficient C57BL/6 J, wild-type C57BL/6 J and A/J mice to Trypanosoma congolense infection.

Authors:  Yoshio Nakamura; Jan Naessens; Masuhiro Takata; Takahide Taniguchi; Kenji Sekikawa; John Gibson; Fuad Iraqi
Journal:  Parasitol Res       Date:  2003-03-19       Impact factor: 2.289

Review 5.  Vaccination against trypanosomiasis: can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?

Authors:  Florencia La Greca; Stefan Magez
Journal:  Hum Vaccin       Date:  2011-11

Review 6.  Salivarian Trypanosomosis: A Review of Parasites Involved, Their Global Distribution and Their Interaction With the Innate and Adaptive Mammalian Host Immune System.

Authors:  Magdalena Radwanska; Nick Vereecke; Violette Deleeuw; Joar Pinto; Stefan Magez
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

7.  Hepatocyte-derived IL-10 plays a crucial role in attenuating pathogenicity during the chronic phase of T. congolense infection.

Authors:  Benoit Stijlemans; Hannelie Korf; Patrick De Baetselier; Lea Brys; Jo A Van Ginderachter; Stefan Magez; Carl De Trez
Journal:  PLoS Pathog       Date:  2020-02-03       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.